Carina Conzelmann
Albert Einstein Allee 23
Ulm, BW 89081, Germany
Ulm, BW 89081, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Detection of SARS-CoV-2 in Human Breast Milk.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: December 19, 2022
The C-terminal 32-mer fragment of hemoglobin alpha is an amyloidogenic peptide with antimicrobial properties.
Journal: Cellular and molecular life sciences : CMLS
Published: November 23, 2022
Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection.
Journal: Frontiers in pediatrics
Published: August 16, 2022
Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infection.
Journal: Journal of medical virology
Published: July 20, 2022
Advanced Molecular Tweezers with Lipid Anchors against SARS-CoV-2 and Other Respiratory Viruses.
Journal: JACS Au
Published: April 07, 2022
Macromolecular Viral Entry Inhibitors as Broad-Spectrum First-Line Antivirals with Activity against SARS-CoV-2.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 09, 2022
In vitro Inhibition of HIV-1 by Cyclotide-Enriched Extracts of Viola tricolor.
Journal: Frontiers in pharmacology
Published: March 03, 2022
BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adults.
Journal: Frontiers in immunology
Published: February 24, 2022
Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture.
Journal: Communications biology
Published: October 26, 2021
Virucidal activity of SARS-CoV-2 rapid antigen extraction buffers.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: October 05, 2021
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.
Journal: EBioMedicine
Published: September 15, 2021
Last Updated: 09/26/2026